Rudy Li

Stock Analyst at Chardan Capital

(0)
# 4977
Out of 5,298 analysts
8
Total ratings
0.00%
Success rate
-35.35%
Average return
Main Sectors:
Top Industries:
3 Stocks
Name Action Price Target Current % Upside Ratings Updated
STOK Stoke Therapeutics
Maintains: Buy
24 24
6.3 280.95% 3 Mar 19, 2025
PRTA Prothena Corp
Maintains: Buy
40 40
11.32 253.36% 3 Feb 21, 2025
MNMD Mind Medicine
Initiates Coverage On: Buy
20
5.55 260.36% 2 Dec 20, 2024